United States · Venture startup

Who invested in Tocagen

9 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$89Mraised across 9 rounds since 2009, from 9 sources

$11MSeries B$9.1MSeries C$3.0MSeries C$7.8MSeries D$5.3MVenture$15MVenture$9.1MVenture$210KVenture$29MVenture
Latest round
Venture, $29MJul 2014
Step-upi
137.2×
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20102011201220132014
$11MSeries B$9.1MSeries C$3.0MSeries C$5.3MVenture$15MVenture$9.1MVenture$210KVenture$29MVenture
First round
Series B, $11M
Jun 2009
Biggest round
$29M
Venture · Jul 2014
Usual gap between rounds
7 months
the median of 7

The rounds

  1. Jul 2014
    Venture$29M

    No investor was named in the report.

    From a historical funding recordSEC filing: $8.5M sold, first sale May 2013

  2. Jun 2013
    Venture$210K

    No investor was named in the report.

    Reported by sec.govSEC filing: $210K sold, first sale May 2013

  3. Dec 2012
    Venture$9.1M

    No investor was named in the report.

    Reported by sec.govSEC filing: $9.1M sold, first sale Feb 2012

  4. Nov 2011
    Venture$15M

    No investor was named in the report.

    Reported by sec.govSEC filing: $15M sold, first sale Dec 2010

  5. Oct 2010
    Venture$5.3M

    No investor was named in the report.

    Reported by sec.govSEC filing: $5.3M sold, first sale Jun 2010

  6. Mar 2010
    Series D$7.8M

    No investor was named in the report.

    Reported by fiercebiotech.comSEC filing: $7.8M sold, first sale Feb 2010

  7. Feb 2010
    Series C$3.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $3.0M sold, first sale Jan 2010

  8. Nov 2009
    Series C$9.1M

    No investor was named in the report.

    Reported by sec.govSEC filing: $9.1M sold, first sale Jun 2009

  9. Jun 2009
    Series B$11M

    No investor was named in the report.

    Reported by sec.govSEC filing: $11M sold, first sale Sept 2008

Also claim to have backed them

This firm lists Tocagen as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Quick answers about Tocagen

How much has Tocagen raised?

Tocagen has raised $89M across 9 rounds since 2009.

When did Tocagen last raise?

Tocagen's most recent round was a Venture of $29M in Jul 2014.

What was Tocagen's biggest round?

Its most recent round, $29M in Jul 2014, is also its largest on record.

What stage is Tocagen at?

Tocagen's latest named round is a Venture, in Jul 2014.

Where is Tocagen based?

Tocagen is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.